Pharmaceutical Distribution APAC Market Intelligence

Are you looking for answers on Pharmaceutical Distribution APAC category?

Are you looking for answers on Pharmaceutical Distribution APAC category?

  • What are the key trends in Pharmaceutical Distribution APAC category?
  • Am I paying the right price?
  • Am I working with the right supplier?
  • What are the major challenges and risks in Pharmaceutical Distribution APAC industry?
  • How is Pharmaceutical Distribution APAC industry performing?

Over 50,000+ users trust Beroe

Report Coverage

  • Top Pharma Whole salers
  • Pricing Model
  • Pharmaceutical Wholesale Distribution Dynamics

Table of contents

  1. Executive Summary
  1. Pharma Distribution: China
  1. Pharma Distribution: Malaysia
  1. Pharma Distribution: Singapore
  1. Pharma Distribution: Taiwan
  1. Pharma Distribution: Thailand
  1. Pharma Distribution: Vietnam
  1. Pharma Distribution: Philippines
  1. Pharma Distribution: Indonesia
  1. Pharma Distribution: Australia
  1. Pharma Distribution: India
  1. Pharma Distribution: South Korea
  1. Pharma Distribution: Japan

Want a more detailed personalised report?

Pharma Distribution: China

The industry is expected to have higher bargain and negotiation power as the market is highly fragmented. Also, implementation of two-invoice system in 2018 is expected to bring down the distributor margins

Manufacturers adopt percentage of sales as a prevalent pricing model by engaging with full-line wholesalers for the distribution of pharmaceutical product.

Engagement Model

  • The multi-channel wholesaler model is the predominant channel used by pharmaceutical companies
  • China has launched the two-invoice system where manufacturer's must engage with first-tier distributors to ensure geographic coverage by restructuring second- or third- tier distributors as first-tier distributors

Distribution Services

  • Percentage of sales is the most widely adopted pricing model by the pharmaceutical companies for engagement with wholesalers

Wholesaler/Distribution Margin

  • Distributor margin ranges between 8–12 percent

Licensing Authority

  • National Development and Reform Commission (NDRC)

Shelf Life

  • Most imported products should have at least six months remaining of their shelf life

Pharma Distribution: Malaysia

Industry is expected to have higher bargaining power as the market is fragmented and also most of the companies prefer to engage with regional distributors such as Zuellig Pharma and DKSH

General practice is to engage with a single national distributor; however, international manufacturers deal with more than one distributors, based on the product portfolio.

Engagement Model

  • Foreign pharmaceutical companies who do not have local subsidiaries prefer to outsource distribution services and manage product registration in-house
  • Multinational companies outsource their complete operations by engaging with single national distributor

Distribution Services

  • Engaging with distributor for Full-line distribution services, commission as percentage of sales value is adopted

Wholesaler/Distribution Margin

  • Distributor margin ranges between 5–15 percent

Sales Incentives

  • On complete outsourcing of the distribution pharmaceutical companies offer incentives on sales target achievement, which is fixed at the beginning of the year

Licensing Authority

  • Drug Control Authority (DCA)

Shelf Life

  • Most imported products should have at least six months remaining of their shelf life     

 

 

 

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.